CE Pricing / Flex Credit

Save with tiered CE Pricing
Starts at $9.98 per contact hour
Min. Hours $$/Hr
4 hours $8.98
8 hours $7.98
12 hours $6.98
20 hours $5.98
30 hours $4.98

Tuberculosis

1.0 Contact Hours / 0.10 AOTA CEUs
Target Audience: Nurses, healthcare professionals, and interested individuals
Purpose/Goal: The outcome of this course is for the learner to describe the epidemiology, signs and symptoms, testing, treatment, and prevention strategies for TB and MDR-TB.
$9.98
Add to Cart

Despite advances in their treatment and prevention, tuberculosis (TB) and multidrug-resistant TB, or MDR-TB, remain two of the world’s deadliest communicable diseases. An ancient disease found in Egyptian mummies, TB and MDR-TB are increasingly difficult to treat, due, in part, to the emergence of drug-resistant strains of the disease and lack of resources necessary to fight the disease.

Upon completion of the course, you will be able to do the following:

  • Describe the epidemiology of tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB) in the United States and globally.
  • Identify signs and symptoms of TB and MDR-TB.
  • Describe how tuberculosis is spread and risk factors for contracting TB and MDR-TB.
  • State tests and treatment strategies for tuberculosis and multidrug-resistant tuberculosis.
  • List strategies to prevent the transmission of TB and MDR-TB.

Tuberculosis (TB) remains one of the world’s deadliest communicable diseases. Evidence of tubercular decay has been found in the spines of ancient Egyptian mummies that are thousands of years old. TB was also common in ancient Greece and Rome as well. While TB has been dramatically reduced because of the discovery of the mycobacterium that causes it and the development of vaccines and medications to treat it, TB has never really been eradicated. Today, TB remains one of the leading causes of infectious deaths throughout the world. Emerging drug-resistant strains of TB pose new challenges in the ever-evolving battle to control and prevent TB (National Institute of Allergy and Infectious Diseases [NIAID], 2017).

Tuberculosis is a disease caused by bacteria, Mycobacterium tuberculosis (Mtb), which spreads from person to person through the air. This rod-shaped bacterium, also called Koch’s bacillus, was discovered by Robert Koch, MD, in 1882 (NIAID, 2017).

Mtb is a small, slow-growing bacterium that can only live in people. It is not found in other animals, insects, soil, or other nonliving things. It is an aerobic bacterium, so it needs oxygen to survive. This is why, during active TB disease, Mtb complexes are always found in the upper air sacs of the lungs (NIAID, 2017).

TB usually affects the lungs but it can spread to other parts of the body, including the brain, kidneys, and spine. In most cases, TB is treatable and curable but individuals can die with TB if they do not get the proper treatment (Centers for Disease Control and Prevention [CDC], 2016b).

Complete the course post exam (CE Test) with a score of 80% or greater. Complete all fields of the course evaluation form. Certificate of Completion is provided once the course post exam is passed per criteria above.

  • American Board of Managed Care Nursing
    The American Board of Managed Care Nursing recognizes all of ALLEGRA Learning Solutions' ANCC accredited courses for continuing education credit for Certified Managed Care Nurses (CMCNs).
  • ANCC - American Nurses Credentialing Center
    ALLEGRA Learning Solutions, LLC is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
  • AOTA - American Occupational Therapy Association
    ALLEGRA Learning Solutions, LLC, is an approved provider of continuing education for occupational therapists by the American Occupational Therapy Association. Approved Provider # 3166
  • California Board of Behavioral Sciences
    California Board of Behavioral Sciences Provider Number PCE 1564. Course meets the qualifications for the stated hours of continuing education credit for MFTs and/or LCSWs as required by the California Board of Behavioral Sciences.
  • California Board of Registered Nursing
    ALLEGRA Learning Solutions is approved by the California Board of Registered Nursing, Provider # CEP 14693 for the number of hours stated.
  • California Department of Health, Aid, and Technician Certification Section
    The California Department of Health, Aid, and Technician Certification Section accepts continuing education offered by CA-BRN approved providers.
  • District of Columbia Board of Nursing
    ALLEGRA Learning Solutions (CE Provider # 50-12076) submits all continuing education records to CE BROKER after successful completion.
  • Florida Board of Nursing
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Board of nursing (CE Provider # 50-12076). Courses are automatically submitted to CE Broker.
  • Florida Board of Nursing - Certified Nursing Assistants
    ALLEGRA Learning Solutions (CE Broker Provider # 50-12076) submits all continuing education records to CE Broker after successful completion.
  • Florida Board of Respiratory Care
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Board of Respiratory Care
  • Florida Council of Dietetics and Nutrition
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Council of Dietetitics and Nutrition
  • Florida Council of Licensed Midwifery
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Council of Licensed Midwifery
  • NAADAC - The National Association of Alcohol and Drug Abuse Counselors
    This course has been approved by ALLEGRA Learning Solutions, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #813, ALLEGRA Learning Solutions, LLC is responsible for all aspects of their programming.
  • NCBTMB -National Certification Board for Therapeutic Massage & Bodywork
    ALLEGRA Learning Solutions, LLC is approved by the National Certification Board for Therapeutic Massage & Bodywork (NCBTMB) as a continuing education Approved Provider. Provider Number 451562-11.
  • Florida Board of Massage Therapists
    ALLEGRA Learning Solutions, LLC is accredited as a provider of continuing education by the Florida Board of Massage Therapists
AOTA CEUs:

0.1

Practice Level:

Intermediate

Content Focus:

Foundational Knowledge

Course Expires:

October 01, 2027

Instructor(s):
  • Cyndie Koopsen, RN, BSN, MBA, HNB-BC, RN-BC, HWNC-BC
  • Caroline Young, MPH
Jurisdictional Requirements:

Continuing education (CE) licensing requirements vary by jurisdiction, are not well defined, and may change. These CE requirements may vary in terms of the number of hours required to the types of courses that must be taken. ALLEGRA Learning Solutions, LLC recommends you contact your licensing board or accrediting organization for the latest continuing education requirements of your state or territory. Compliance with CE requirements is the responsibility of the individual health care provider. Health care providers must understand the CE requirements in their jurisdictions, and be sure they are up-to-date on any rule changes that affect their license. For further information, please see our Accreditation Information.

Accommodations for Disabilities:

Every effort will be made to accommodate your special needs. To request accommodations, please contact us.

Conflicts of Interest and Relevant Financial Relationships:

The authors/planning committee members have no conflicts of interests or relevant financial relationships to declare relevant to this activity.

Commercial Support:

No commercial support has been received for this activity.

Non-endorsement of products:

Accreditation refers to recognition of continuing nursing education only and does not imply ALLEGRA Learning Solutions, LLC approval or endorsement of any commercial product.

Off-label Use of Products:

None of the authors intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Cart

0.0
Hrs